| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |